Cancer patients are one of the risk groups to become infected with the COVID-19 virus and are more likely to have complications from this infection. Two research projects were launched to better protect this vulnerable group: MOCOR; vulnerability research for COVID-19 and COREO; research into home monitoring.
The MOCOR project aims to better understand the vulnerability to COVID-19 in cancer patients. By means of blood samples, we investigate whether cancer antibodies against SARS-CoV-2 have been built up and the immune parameters are measured in cancer patients. In addition, this research will more quickly identify cancer patients who are extra sensitive to COVID-19 in order to prevent serious complications from the infection.
Hospitals are currently a source of infection for the SAR-Cov-2 virus. In the COREO project, our researchers on cancer patients are less likely to become infected with COVID-19 if they are treated at home as much as possible.
This study compares cancer treatments in a home setting with classic cancer treatments at UZA and AZ Middelares Hospital Ghent. It is being investigated whether there are differences in the frequency and severity of the COVID-19 infections and the safety and effectiveness of the cancer treatments. For example, our researchers hope to demonstrate that a combined use of virtual technology and home care can make cancer treatment safer in times of COVID-19.